AUBERTON-HERVE ANDRE-JACQUES 4
4 · Bionik Laboratories Corp. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
AUBERTON-HERVE ANDRE-JACQUES
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2021-07-15$3.60/sh+51,878$186,501→ 276,353 total(indirect: Shares held through Star SCI or 4A Consulting and Engineering) - Exercise/Conversion
Stock Option (right to buy)
2021-07-15−7,500→ 0 totalExercise: $3.16Exp: 2026-05-31→ Common Stock, par value $0.001 per share (7,500 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2021-07-15$3.16/sh+7,500$23,700→ 283,853 total(indirect: Shares held through Star SCI or 4A Consulting and Engineering) - Exercise/Conversion
Stock Option (right to buy)
2021-07-15−51,878→ 63,881 totalExercise: $3.60From: 2020-07-26Exp: 2026-07-26→ Common Stock, par value $0.001 per share (51,878 underlying)
Holdings
- 95,149
Common Stock, par value $0.001 per share
Footnotes (2)
- [F1]Payment of exercise price was satisfied through the satisfaction of an Issuer promissory note held by the reporting person.
- [F2]The options vest 2,500 on May 31, 2019, 2,500 on November 30, 2019 and 2,500 on May 31, 2020.